Literature DB >> 1958500

Acyclovir: mechanism of antiviral action and potentiation by ribonucleotide reductase inhibitors.

J E Reardon1, T Spector.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1958500     DOI： 10.1016/s1054-3589(08)60031-9

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  4 in total

1.  Strategic design and three-dimensional analysis of antiviral drug combinations.

Authors:  M N Prichard; L E Prichard; C Shipman
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

2.  Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.

Authors:  T Spector; D C Lobe; M N Ellis; T A Blumenkopf; G M Szczech
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

3.  Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum: a target for antimalarial therapy.

Authors:  H Rubin; J S Salem; L S Li; F D Yang; S Mama; Z M Wang; A Fisher; C S Hamann; B S Cooperman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

Review 4.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.